Second Annual World Drug Safety Congress

16th September 2008 - 19th September 2008

First announcement

Key Conference Topics
• Global Regulatory Overview including the latest developments from the FDA, EMEA, MHLW • Electronic Submissions • Safety Data Management • QPPV • Signal Detection • Risk Management • Clinical Safety • Post Marketing Surveillance • Operational Optimisation

Venue

16th September 2008 - 19th September 2008

London: Hilton Paddington
Warwick Road
London
SW5 9TA
UK
T: 020 7370 8532

Download Brochure

Fill out the form below to download the event brochure.

Fields in bold are mandatory
 

Title

First Name

Last Name

Job Title

Organisation

Email

Phone

Mobile

Fax

Address

Address

City

County

Postcode

Country Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Colombia Comoros Congo Congo, The Democratic Republic of the Cook Islands Costa Rica Cote Divoire Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican REPUBLIC Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Virgin Islands, British Virgin Islands, U.S. Wallis and Futuna Western Sahara Yemen Yugoslavia Zambia Zimbabwe

Where did you hear about the event? Mailshot Colleague Website Publication Email

I would like to receive the brochure by PDF Mail

Comments

Workshop & Seminars

Further information to follow

Sponsors & Partners

For further information on Sponsorship and Exhibitions please click here.

Speakers

Hugo Stephenson, President, Quintiles Strategic Research Services

Christopher-Paul Milne, Associate Director, Tufts Centre for the Study of Drug Development

Osamu Doi, Chief Executive, Society of Japanese Pharmacopoeia

Vicki Edwards, Director, European Pharmacovigilance, Abbott Laboratories

Sabina Straus, Head of Drug Safety Department, Medicines Evaluation Board, The Netherlands

Charles Beasley, Chief Scientific Officer Global Product Safety, Eli Lilly

Juhanna Idänpään-Heikkilä, Senior Adviser, CIOMS c/o WHO

Tjeerd Van Staa, GPRD, MHRA

Carmen Bozic, VP Drug Safety and Risk Management, Biogen Idec

John Ferguson, VP Global Head of Pharmacovigilence and Medical Safety, Novartis

Songlin Xue, VP Global Head of Epidemiology, Novartis

Shelly Ghandi, Pharmacovigilance Information Unit Manager, MHRA

Guy Pawson, Manager Electronic Submissions, Genentech

Phil Berry, Global Medicines Director, Reckitt Benckiser

John Balian, SVP Global Pharmacovigilance and Epidemiology, Bristol-Myers Squibb

Michael Bone, Association of Research Ethics Committees

Dr John Talbot, Director, Clinical Drug Safety an, Processes and Standards, AstraZeneca R&D

Vivianne Arencibia, Global Head Compliance and Audit, Group Quality Operations, Novartis

Magda Daudin, Head of Pharmacovigilance Inspections, Afssaps

Stewart Jessamine, Interim Manager, Medsafe, New Zealand

Georg Ferber, Group Head Biostatistics Cardiovascular, Novartis

Katia Yamasaki, Pharmacovigilance Manager, Stiefel R&D Latin America

Kasia Petchel MD, VP & Global Head Safety Risk Management, Roche

Dana Bagan, Head of Drug Safety, GlaxoSmithKline

William Maier, Senior Director Epidemiology, Elan Pharma Ltd

Registration for Second Annual World Drug Safety Congress